Lale Öcal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lale Öcal has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Gül
Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
9 shared publications - Bahar Artim-Esen
Division of Rheumatology, Department of Internal Medicine, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkiye
9 shared publications - Murat Inanc
Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
9 shared publications - Yasemin Yalçınkaya
Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
9 shared publications - Murat Bektaş
Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
2 shared publications - Shirkhan Amikishiyev
Division of Internal Medicine, Faculty of Medicine and Health Sciences, Qarabağ University
2 shared publications
Latest Publications
- Open Access
- 12 December 2023
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 53 (6) , 1704-1712
Efficacy of rituximab on disease activity, severity, and disease-related damage in patients with immunosuppressive-resistant systemic sclerosis
Background/aim: B-cell depletion with rituximab (RTX) is widely used as a rescue therapy in patients with systemic sclerosis (SSc). The aim herein was to analyze the progress of disease-related outcomes after RTX therapy in severe SSc patients. Materials and methods: Included in this study were 27 SSc patients who were followed-up between 2012 and 2020 and received at least 1 cycle of RTX for active disease, despite receiving standard immunosuppressives (ISs). In addition to the European Scleroderma Study Group and European Scleroderma Trials and Research Group activity scores, Medsger's severity, and the recently developed Scleroderma Clinical Trials Consortium Damage Index values were evaluated initially and at 1 year after the first infusion. The progress of individual organ damage was also assessed at the end of the follow-up period (at least 6 months after the last infusion) using the data extracted from the medical records. Results: Disease activity and severity-improved and disease-related overall damage worsened after the first year of RTX therapy (p < 0.001, p = 0.008, and p = 0.005). Some of the disease-related organ damage had improved at the end of the follow-up period, indicating its reversibility. Overall damage scores -11 after the first year of RTX therapy were found to be associated with mortality (p = 0.035). Conclusion: RTX contributed to reducing the activity and severity in SSc patients with severe disease, nonetheless the efficacy related to the damage was limited. High damage scores in the first year were found to be associated with mortality. Spontaneous progress of manifestations requiring a longer period to improve and irregular consecutive RTX courses might lead to difficulties in differentiation between activity and damage.
- 12 December 2023
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 53 (6) , 1704-1712
Open AccessEfficacy of rituximab on disease activity, severity, and disease-related damage in patients with immunosuppressive-resistant systemic sclerosis
Background/aim: B-cell depletion with rituximab (RTX) is widely used as a rescue therapy in patients with systemic sclerosis (SSc). The aim herein was to analyze the progress of disease-related outcomes after RTX therapy in severe SSc patients. Materials and methods: Included in this study were 27 SSc patients who were followed-up between 2012 and 2020 and received at least 1 cycle of RTX for active disease, despite receiving standard immunosuppressives (ISs). In addition to the European Scleroderma Study Group and European Scleroderma Trials and Research Group activity scores, Medsger's severity, and the recently developed Scleroderma Clinical Trials Consortium Damage Index values were evaluated initially and at 1 year after the first infusion. The progress of individual organ damage was also assessed at the end of the follow-up period (at least 6 months after the last infusion) using the data extracted from the medical records. Results: Disease activity and severity-improved and disease-related overall damage worsened after the first year of RTX therapy (p < 0.001, p = 0.008, and p = 0.005). Some of the disease-related organ damage had improved at the end of the follow-up period, indicating its reversibility. Overall damage scores -11 after the first year of RTX therapy were found to be associated with mortality (p = 0.035). Conclusion: RTX contributed to reducing the activity and severity in SSc patients with severe disease, nonetheless the efficacy related to the damage was limited. High damage scores in the first year were found to be associated with mortality. Spontaneous progress of manifestations requiring a longer period to improve and irregular consecutive RTX courses might lead to difficulties in differentiation between activity and damage.
- 28 September 2022
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 62 (5) , 1903-1909
Improved sensitivity of the skin pathergy test with polysaccharide pneumococcal vaccine antigens in the diagnosis of Behçet disease
Objective: The skin pathergy test (SPT) is an important tool in the diagnosis of Behçet disease (BD), but its decreasing sensitivity over years has resulted in less frequent use in the clinical practice. This study aimed to improve the sensitivity of the SPT without compromising its specificity. Methods: BD patients, patients with other inflammatory diseases, recurrent aphthous stomatitis, and healthy controls comprised the study group. The SPT was conducted using 20G needle and 21G lancet pricks, or with additional application of 23-valent polysaccharide pneumococcal vaccine (PS-23), Alum, or ATP to the prick site. Development of erythema and induration at 24 h/48 h were evaluated by the same observer. Induration (≥2 mm) with erythema at 48 h was accepted as a positive reaction. Proinflammatory cytokine production following stimulation with lipopolysaccharide or PS-23 was investigated by whole-blood assay (WBA) in a subgroup. Results: Stimulation of the forearm skin by PS-23 and a 20G needle prick showed the highest sensitivity and specificity in BD (64.3% and 100%, respectively), especially in patients with active disease (80.3% and 100%, respectively), compared with a sensitivity of 4.8% in all and 6.1% in active patients using a single 20G prick. A positive result was associated with active disease and no use of immunosuppressives. In WBA, increased IL-1β and IL-1Ra production in response to PS-23 was observed in the group with active BD, while the cytokine response to lipopolysaccharide was similar in all groups. Conclusions: The SPT conducted using a 20G needle prick and PS-23 antigens was shown to be a promising tool for the diagnosis of BD owing to its improved sensitivity compared with the standard approach.
- 28 September 2022
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 62 (5) , 1903-1909
Improved sensitivity of the skin pathergy test with polysaccharide pneumococcal vaccine antigens in the diagnosis of Behçet disease
Objective: The skin pathergy test (SPT) is an important tool in the diagnosis of Behçet disease (BD), but its decreasing sensitivity over years has resulted in less frequent use in the clinical practice. This study aimed to improve the sensitivity of the SPT without compromising its specificity. Methods: BD patients, patients with other inflammatory diseases, recurrent aphthous stomatitis, and healthy controls comprised the study group. The SPT was conducted using 20G needle and 21G lancet pricks, or with additional application of 23-valent polysaccharide pneumococcal vaccine (PS-23), Alum, or ATP to the prick site. Development of erythema and induration at 24 h/48 h were evaluated by the same observer. Induration (≥2 mm) with erythema at 48 h was accepted as a positive reaction. Proinflammatory cytokine production following stimulation with lipopolysaccharide or PS-23 was investigated by whole-blood assay (WBA) in a subgroup. Results: Stimulation of the forearm skin by PS-23 and a 20G needle prick showed the highest sensitivity and specificity in BD (64.3% and 100%, respectively), especially in patients with active disease (80.3% and 100%, respectively), compared with a sensitivity of 4.8% in all and 6.1% in active patients using a single 20G prick. A positive result was associated with active disease and no use of immunosuppressives. In WBA, increased IL-1β and IL-1Ra production in response to PS-23 was observed in the group with active BD, while the cytokine response to lipopolysaccharide was similar in all groups. Conclusions: The SPT conducted using a 20G needle prick and PS-23 antigens was shown to be a promising tool for the diagnosis of BD owing to its improved sensitivity compared with the standard approach.
- 22 December 2021
- Published by Galenos Yayinevi in Ulusal Romatoloji Dergisi
- Vol. 13 (3) , 116-120
Real life data of secukinumab in ankylosing spondylitis and psoriatic arthritis: Analysis of 44 patients in a single center
- 22 December 2021
- Published by Galenos Yayinevi in Ulusal Romatoloji Dergisi
- Vol. 13 (3) , 116-120
Real life data of secukinumab in ankylosing spondylitis and psoriatic arthritis: Analysis of 44 patients in a single center
- 22 December 2021
- Published by Galenos Yayinevi in Ulusal Romatoloji Dergisi
- Vol. 13 (3) , 100-106
Clinical characteristics of female patients with axial spondyloarthritis treated with tumor necrosis factor-alpha inhibitors and disease related outcomes after therapy
- 22 December 2021
- Published by Galenos Yayinevi in Ulusal Romatoloji Dergisi
- Vol. 13 (3) , 100-106
Clinical characteristics of female patients with axial spondyloarthritis treated with tumor necrosis factor-alpha inhibitors and disease related outcomes after therapy
- 5 February 2021
- Published by Springer Nature in Rheumatology International
- Vol. 41 (9) , 1667-1672
A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls
We aimed to analyse the distribution of HLA Class 2 genotypes which were reported among the genetic risk factors for ANCA-associated vasculitis (AAV) among Turkish patients in comparison with healthy subjects and previously reported data of AAV cohorts. Ninety-eight patients (F/M: 47/51 and mean age: 49 ± 1.14) were enrolled in the study and records of gender and birthplace-matched 196 healthy kidney donors were used as the control group. Patients were classified according to the clinical subgroups and ANCA serotypes (MPO-AAV, PR3-AAV). DNA was isolated from venous blood from all patients, and high-resolution HLA Class 2 genotyping was carried out by using NGS-Omixon Holotype HLA Kit. The frequencies of HLA-DQB1*03:03, - *06:04, and -DPB1*13:01, -*16:01 and -*66:01:00 alleles were significantly higher, and the frequencies of HLA-DQB1*02:02, -DPB1*02:01 and -*04:01 alleles were lower in the PR3-AAV subgroup (n = 53) compared to the controls. Comparison of amino acid sequences of the associated HLA-DPB1 alleles revealed the sequence of D-E-A-V in risk alleles replaced with the G-G-P-M sequence in protective alleles between 84 and 87th positions. Structural analysis of the HLA-DPB1*02:01 showed that this shared position is in the contact area between HLA-DP α and β chains and within pocket 1 of the antigen-binding groove. First HLA genotyping analysis in Turkish AAV patients revealed a negative correlation between PR3-ANCA positivity and certain HLA-DPB1 alleles contradictory to the results reported from European cohorts. Known functional effects of D-E-A-V sequence on HLA-DPB1 support the importance of our finding, but further studies are needed to reveal its pathogenic mechanisms.
- 5 February 2021
- Published by Springer Nature in Rheumatology International
- Vol. 41 (9) , 1667-1672
A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls
We aimed to analyse the distribution of HLA Class 2 genotypes which were reported among the genetic risk factors for ANCA-associated vasculitis (AAV) among Turkish patients in comparison with healthy subjects and previously reported data of AAV cohorts. Ninety-eight patients (F/M: 47/51 and mean age: 49 ± 1.14) were enrolled in the study and records of gender and birthplace-matched 196 healthy kidney donors were used as the control group. Patients were classified according to the clinical subgroups and ANCA serotypes (MPO-AAV, PR3-AAV). DNA was isolated from venous blood from all patients, and high-resolution HLA Class 2 genotyping was carried out by using NGS-Omixon Holotype HLA Kit. The frequencies of HLA-DQB1*03:03, - *06:04, and -DPB1*13:01, -*16:01 and -*66:01:00 alleles were significantly higher, and the frequencies of HLA-DQB1*02:02, -DPB1*02:01 and -*04:01 alleles were lower in the PR3-AAV subgroup (n = 53) compared to the controls. Comparison of amino acid sequences of the associated HLA-DPB1 alleles revealed the sequence of D-E-A-V in risk alleles replaced with the G-G-P-M sequence in protective alleles between 84 and 87th positions. Structural analysis of the HLA-DPB1*02:01 showed that this shared position is in the contact area between HLA-DP α and β chains and within pocket 1 of the antigen-binding groove. First HLA genotyping analysis in Turkish AAV patients revealed a negative correlation between PR3-ANCA positivity and certain HLA-DPB1 alleles contradictory to the results reported from European cohorts. Known functional effects of D-E-A-V sequence on HLA-DPB1 support the importance of our finding, but further studies are needed to reveal its pathogenic mechanisms.
- Open Access
- 1 January 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (1) , 76-82
Interstitial lung disease in patients with systemic lupus erythematosus: A cohort study
Systemic lupus erythematosus (SLE) is an autoimmune disease with a variety of organ/system involvement. Respiratory system involvement is common in these patients and usually manifests itself by disorders of the lung parenchyma, pleura, pulmonary vasculature or diaphragm. In this study, we sought to determine the frequency of interstitial lung disease (ILD) in patients with SLE and associated risk factors. Three hundred randomly chosen patients with SLE were included. Chest x-ray (CXR), lung spirometry and carbon monoxide diffusion test (DLCO) were performed. High-resolution thorax computed tomography (HRCT) was performed for a definite diagnosis of ILD. . Of 300 patients, 16% had ILD. At the start of the study, the prevalence obtained from the patients' records showed that 4% had ILD. The median age, mean duration of disease, and follow-up time were significantly higher and longer in patients with ILD compared to patients without (p < 0.05). Forced expiratory volume (FEV1), forced vital capacity (FVC), DLCO and total lung capacity (TLC) were significantly lower in patients with ILD (p < 0.001). Patients with ILD had a significantly higher frequency of arthritis, serositis, Raynaud's phenomenon, myositis, and anti-Scl70 positivity (p = 0.01, 0.001, 0.02, 0.004, and 0.001, respectively). A significantly higher number of patients had stopped using hydroxychloroquine (HCQ) in the ILD group (p = 0.04).
- 1 January 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (1) , 76-82
Open AccessInterstitial lung disease in patients with systemic lupus erythematosus: A cohort study
Systemic lupus erythematosus (SLE) is an autoimmune disease with a variety of organ/system involvement. Respiratory system involvement is common in these patients and usually manifests itself by disorders of the lung parenchyma, pleura, pulmonary vasculature or diaphragm. In this study, we sought to determine the frequency of interstitial lung disease (ILD) in patients with SLE and associated risk factors. Three hundred randomly chosen patients with SLE were included. Chest x-ray (CXR), lung spirometry and carbon monoxide diffusion test (DLCO) were performed. High-resolution thorax computed tomography (HRCT) was performed for a definite diagnosis of ILD. . Of 300 patients, 16% had ILD. At the start of the study, the prevalence obtained from the patients' records showed that 4% had ILD. The median age, mean duration of disease, and follow-up time were significantly higher and longer in patients with ILD compared to patients without (p < 0.05). Forced expiratory volume (FEV1), forced vital capacity (FVC), DLCO and total lung capacity (TLC) were significantly lower in patients with ILD (p < 0.001). Patients with ILD had a significantly higher frequency of arthritis, serositis, Raynaud's phenomenon, myositis, and anti-Scl70 positivity (p = 0.01, 0.001, 0.02, 0.004, and 0.001, respectively). A significantly higher number of patients had stopped using hydroxychloroquine (HCQ) in the ILD group (p = 0.04).
- 21 December 2020
- Published by Galenos Yayinevi in Ulusal Romatoloji Dergisi
- Vol. 12 (3) , 83-87
Cardiovascular risk in antiphospholipid syndrome: A comparison of thrombotic and obstetric disease subsets
- 21 December 2020
- Published by Galenos Yayinevi in Ulusal Romatoloji Dergisi
- Vol. 12 (3) , 83-87
Cardiovascular risk in antiphospholipid syndrome: A comparison of thrombotic and obstetric disease subsets
- 28 October 2020
- Published by Springer Nature in Rheumatology International
- Vol. 41 (2) , 439-448
Long-term follow-up of 89 patients with giant cell arteritis: a retrospective observational study on disease characteristics, flares and organ damage
The objective of the study is to investigate the clinical characteristics and long-term prognosis including flares and organ damage in patients with giant cell arteritis (GCA) from a tertiary referral centre and compare these features in different subgroups. In this retrospective observational study, patients with GCA who were followed up in our vasculitis clinic between 1998 and 2018 were evaluated by a predefined protocol. Patients with and without cranial symptoms were compared for clinical and laboratory features, flares and permanent damage findings. Vasculitis Damage Index and Large Vessel Vasculitis Index of Damage were used for damage assessment. Records of 89 patients (median follow-up time 46 months) were analysed; mean time to diagnosis after initial symptom was longer in patients with acute vision loss (11 ± 4 vs. 4.8 ± 1.1 months p = 0.002). EGG (n = 19) was younger (63 ± 2 vs. 69 ± 1 years old p = 0.01); had higher mean CRP (141.8 ± 107.3 vs. 76.6 ± 67.9 mg/dL p = 0.023) and ESR (120.8 ± 25.1 vs. 99.3 ± 24.3 mm/h p = 0.004) at diagnosis. PET–CT detected large vessel vasculitis in 42/48 (87.5%) cases of the entire cohort. Thirty-one patients had flares and proportion of flared patients was significantly higher in patients with cranial symptoms. At least one damage item (DI) was present in 54 (60.7%) patients. The development of damage was found to be associated with flares. Evaluation of our cohort revealed the importance of early diagnosis for prevention of vision loss in GCA. Patients without cranial symptoms were younger, present with higher inflammatory response and for these, PET–CT was the main diagnostic tool. Relapse rate was higher in patients with cranial symptoms. Flares and accompanying corticosteroid treatment may contribute to organ damage in GCA.
- 28 October 2020
- Published by Springer Nature in Rheumatology International
- Vol. 41 (2) , 439-448
Long-term follow-up of 89 patients with giant cell arteritis: a retrospective observational study on disease characteristics, flares and organ damage
The objective of the study is to investigate the clinical characteristics and long-term prognosis including flares and organ damage in patients with giant cell arteritis (GCA) from a tertiary referral centre and compare these features in different subgroups. In this retrospective observational study, patients with GCA who were followed up in our vasculitis clinic between 1998 and 2018 were evaluated by a predefined protocol. Patients with and without cranial symptoms were compared for clinical and laboratory features, flares and permanent damage findings. Vasculitis Damage Index and Large Vessel Vasculitis Index of Damage were used for damage assessment. Records of 89 patients (median follow-up time 46 months) were analysed; mean time to diagnosis after initial symptom was longer in patients with acute vision loss (11 ± 4 vs. 4.8 ± 1.1 months p = 0.002). EGG (n = 19) was younger (63 ± 2 vs. 69 ± 1 years old p = 0.01); had higher mean CRP (141.8 ± 107.3 vs. 76.6 ± 67.9 mg/dL p = 0.023) and ESR (120.8 ± 25.1 vs. 99.3 ± 24.3 mm/h p = 0.004) at diagnosis. PET–CT detected large vessel vasculitis in 42/48 (87.5%) cases of the entire cohort. Thirty-one patients had flares and proportion of flared patients was significantly higher in patients with cranial symptoms. At least one damage item (DI) was present in 54 (60.7%) patients. The development of damage was found to be associated with flares. Evaluation of our cohort revealed the importance of early diagnosis for prevention of vision loss in GCA. Patients without cranial symptoms were younger, present with higher inflammatory response and for these, PET–CT was the main diagnostic tool. Relapse rate was higher in patients with cranial symptoms. Flares and accompanying corticosteroid treatment may contribute to organ damage in GCA.
- 15 March 2018
- Published by Istanbul University in İstanbul Tıp Fakültesi Dergisi
- Vol. 81 (1) , 11-16
THE ROLE OF 21-HYDROXYLASE DEFICIENCY IN THE PATHOGENESIS OF BEHÇET DISEASE
Amaç: Akne benzeri deri lezyonlarının sıklığı ve hastalığın erkeklerde daha ağır seyretmesi Behçet hastalığı (BH) patogenezinde seks hormonlarının rolünün olabileceğini düşündürmektedir. HLA-B51 BH için en önemli genetik duyarlılık faktörüdür. Konjenital adrenal hiperplazi (KAH)’lerin çoğundan sorumlu olan CYP21A2 geni kromozom 6p21.3’deki MHC bölgesinde yerleşimlidir. Bu çalışmada CYP21A2 genindeki olası bazı mutasyonların HLA-B51 ile bağlantı dengesizliği göstererek 21-hidroksilaz eksikliğine ve bunun sonucunda androjen fazlalığına yol açarak BH patogenezine katkı yapabileceği hipotezini araştırmayı amaçladık. Hastalar ve Yöntem: Çalışma grubunu 18 sağlıklı kontrol, 29 BH olan hasta ve 15 ankilozan spondilit (AS) hastası oluşturdu. Bütün hastalara ACTH uyarı testi yapıldı. Bazal ve ACTH uyarısı sonrası serum kortizol ve 17-OH-progesteron (17-OH-P) düzeyleri ve bazal dehidroepiandrosteron sülfat (DHEA-S), total testosteron ve seks hormonu bağlayıcı globulin (SHBG) düzeyleri ölçüldü. Bulgular: Kılavuzların önerdiği şekilde, klasik olmayan KAH tanısı için 17-OH-P için eşik değer olarak 10 ng/ml alındı. ACTH uyarısı sonrası 3 BH (%10.3) ve 5 AS hastasının (%33.3) 17-OH-P düzeyleri yüksek bulundu. Bu hastaların klasik olmayan KAH hastaları ya da KAH mutasyonları için taşıyıcı olabileceği düşünüldü. Belirgin aknesi olan 8 BH’dan üçünün biyokimyasal değerleri klasik olmayan KAH ile uyumluydu. BH olanların ortalama total testosteron düzeylerinin sağlıklı kontrollerinkinden anlamlı olarak düşük olduğu görüldü. Bununla birlikte 17-OH-P düzeyi yüksek olan hastalarda testosteron düzeyleri normaldi. Sonuç: Bu pilot çalışmada BH ve AS hastalarının bir grubunda ACTH uyarısı sonrası yüksek 17-OH-P değerleri gözlemledik. Bulgularımız HLA-B allelleri ile bağlantı dengesizliği gösteren olası 21-hidroksilaz eksikliğinin patogeneze katkısının olabileceğini düşündürmekte ve verilerin genetik çalışmalarla doğrulanmasını gerektirmektedir.
- 15 March 2018
- Published by Istanbul University in İstanbul Tıp Fakültesi Dergisi
- Vol. 81 (1) , 11-16
THE ROLE OF 21-HYDROXYLASE DEFICIENCY IN THE PATHOGENESIS OF BEHÇET DISEASE
Amaç: Akne benzeri deri lezyonlarının sıklığı ve hastalığın erkeklerde daha ağır seyretmesi Behçet hastalığı (BH) patogenezinde seks hormonlarının rolünün olabileceğini düşündürmektedir. HLA-B51 BH için en önemli genetik duyarlılık faktörüdür. Konjenital adrenal hiperplazi (KAH)’lerin çoğundan sorumlu olan CYP21A2 geni kromozom 6p21.3’deki MHC bölgesinde yerleşimlidir. Bu çalışmada CYP21A2 genindeki olası bazı mutasyonların HLA-B51 ile bağlantı dengesizliği göstererek 21-hidroksilaz eksikliğine ve bunun sonucunda androjen fazlalığına yol açarak BH patogenezine katkı yapabileceği hipotezini araştırmayı amaçladık. Hastalar ve Yöntem: Çalışma grubunu 18 sağlıklı kontrol, 29 BH olan hasta ve 15 ankilozan spondilit (AS) hastası oluşturdu. Bütün hastalara ACTH uyarı testi yapıldı. Bazal ve ACTH uyarısı sonrası serum kortizol ve 17-OH-progesteron (17-OH-P) düzeyleri ve bazal dehidroepiandrosteron sülfat (DHEA-S), total testosteron ve seks hormonu bağlayıcı globulin (SHBG) düzeyleri ölçüldü. Bulgular: Kılavuzların önerdiği şekilde, klasik olmayan KAH tanısı için 17-OH-P için eşik değer olarak 10 ng/ml alındı. ACTH uyarısı sonrası 3 BH (%10.3) ve 5 AS hastasının (%33.3) 17-OH-P düzeyleri yüksek bulundu. Bu hastaların klasik olmayan KAH hastaları ya da KAH mutasyonları için taşıyıcı olabileceği düşünüldü. Belirgin aknesi olan 8 BH’dan üçünün biyokimyasal değerleri klasik olmayan KAH ile uyumluydu. BH olanların ortalama total testosteron düzeylerinin sağlıklı kontrollerinkinden anlamlı olarak düşük olduğu görüldü. Bununla birlikte 17-OH-P düzeyi yüksek olan hastalarda testosteron düzeyleri normaldi. Sonuç: Bu pilot çalışmada BH ve AS hastalarının bir grubunda ACTH uyarısı sonrası yüksek 17-OH-P değerleri gözlemledik. Bulgularımız HLA-B allelleri ile bağlantı dengesizliği gösteren olası 21-hidroksilaz eksikliğinin patogeneze katkısının olabileceğini düşündürmekte ve verilerin genetik çalışmalarla doğrulanmasını gerektirmektedir.
- 1 November 2016
- Published by Elsevier in Microvascular Research
- Vol. 108, 17-21
Capillaroscopic findings and vascular biomarkers in systemic sclerosis: Association of low CD40L levels with late scleroderma pattern
- 1 November 2016
- Published by Elsevier in Microvascular Research
- Vol. 108, 17-21
Capillaroscopic findings and vascular biomarkers in systemic sclerosis: Association of low CD40L levels with late scleroderma pattern